|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net operating revenues | |||||
| Grant income | |||||
| Equity in earnings of unconsolidated affiliates | |||||
| Operating expenses: | |||||
| Salaries, wages and benefits | |||||
| Supplies | |||||
| Other operating expenses, net | |||||
| Depreciation and amortization | |||||
| Impairment and restructuring charges, and acquisition-related costs | |||||
| Litigation and investigation costs | |||||
| Net gains on sales, consolidation and deconsolidation of facilities | |||||
| Litigation and investigation costs | |||||
| Net losses (gains) on sales, consolidation and deconsolidation of facilities | |||||
| Operating income | |||||
| Interest expense | |||||
| Other non-operating income, net | |||||
| Loss from early extinguishment of debt | |||||
| Income before income taxes | |||||
| Income tax expense | |||||
| Income from continuing operations, before discontinued operations | |||||
| Income (loss) from operations | |||||
| Net income | |||||
| Less: Net income available to noncontrolling interests | |||||
| Net income available to Tenet Healthcare Corporation common shareholders | |||||
| Income from continuing operations, net of tax | |||||
| Earnings available to Tenet Healthcare Corporation common shareholders: | |||||
| Continuing operations (in dollars per share) | |||||
| Discontinued operations (in dollars per share) | |||||
| Basic earnings per share (in dollars per share) | |||||
| Diluted earnings per share (in dollars per share) | |||||
| Weighted average shares and dilutive securities outstanding (in thousands): | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...